Advertisement

Topics

Sandoz International GmbH Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

20:30 EDT 6 Oct 2018 | BioPortfolio Reports

Sandoz International GmbH Strategy, SWOT and Corporate Finance Report


Summary


Sandoz International GmbH Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Sandoz International GmbH Sandoz or the company', the generic business division of Novartis, is engaged in the development, manufacture and marketing of prescription medicines, as well as pharmaceutical active ingredients. Sandoz has its presence in the US, Europe, Asia, Africa, Australasia, Canada and Latin America. The company is headquartered in Holzkirchen, Germany.


Scope


Detailed information on Sandoz International GmbH required for business and competitor intelligence needs

A study of the major internal and external factors affecting Sandoz International GmbH in the form of a SWOT analysis

An indepth view of the business model of Sandoz International GmbH including a breakdown and examination of key business segments

Intelligence on Sandoz International GmbH's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Sandoz International GmbH, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Sandoz International GmbH and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Sandoz International GmbH as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Sandoz International GmbH's business structure, strategy and prospects.

Original Article: Sandoz International GmbH Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Sandoz International GmbH Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...